FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 141 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $307,310 | +177.2% | 15,404 | -4.3% | 0.00% | – |
| Q2 2022 | $110,846 | -24.8% | 16,088 | +1.5% | 0.00% | – |
| Q1 2022 | $147,340 | -45.8% | 15,843 | -17.1% | 0.00% | – |
| Q4 2021 | $272,000 | -35.1% | 19,110 | +5.9% | 0.00% | – |
| Q3 2021 | $419,000 | -6.9% | 18,047 | -0.1% | 0.00% | – |
| Q2 2021 | $450,000 | -3.8% | 18,067 | +8.2% | 0.00% | – |
| Q1 2021 | $468,000 | +33.3% | 16,692 | +66.0% | 0.00% | – |
| Q4 2020 | $351,000 | -18.4% | 10,057 | +16.5% | 0.00% | – |
| Q3 2020 | $430,000 | – | 8,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |